2019 Annual awards dinner
SWHR celebrated achievements, advancements, and innovations in women’s health at our annual awards dinner in Washington, D.C.
SWHR thanks all who attended the 29th Annual Awards Dinner at the InterContinental Washington DC — The Wharf.
Hundreds of supporters gathered to celebrate advancements in women’s health at the 29th Annual Awards Dinner. Check out highlights from the event and see the photo gallery in our blog post.
Our 2019 Honorees
Meet the Visionary Award Winners
Carolyn Clancy, MD
As a highly experienced physician executive. Dr. Clancy has held several leadership positions at VHA. In her current role as Deputy Under Secretary for Health for Discovery, Education and Affiliate Networks, Veterans Health Administration (VHA), she works to foster collaboration between the VA and its affiliates. Previously, as VHA’s Executivein-Charge, she oversaw a health system delivering care to more than 9 million veterans. Before coming to VHA, Dr. Clancy was Director of the Agency for Healthcare Research and Quality for 10 years. In these influential roles, she has worked to enhance access to and quality of care for women.
John J. Seng
A public relations veteran of nearly 40 years, Mr. Seng is a past SWHR Board member and a longtime supporter of the organization and its mission to eliminate imbalances in health care for women through science, policy, and education. A public relations veteran, he launched Spectrum Science Communications 22 years ago and led its development into a top-tier, award-winning health and life sciences communications firm. He also founded GLOBALHealthPR, the largest independent health and science communications agency partnership worldwide, and has earned numerous honors for his communications work.
Cen Xu, PhD
Dr. Xu is Scientific Director of Neuroscience Discovery Research at Amgen. With 30+ years of neuroscience research experience, Xu joined Amgen in 2016 as a key contributor in building the company’s neuroscience strategy. She is a co-inventor for the first FDA-approved treatment designed to prevent migraine, which affects 18% of women in the U.S. She has also aided in the discovery and development of other therapeutics, including for schizophrenia and sleep disorders. Her areas of focus include neurodegeneration, psychiatry disorders, migraine, and analgesia.